Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Steinman

Showing results (61-70 of 335) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|March 7, 2006
What went wrong in the natalizumab trials?Annette Langer-Gould, Lawrence Steinman
Neurology|October 9, 2002
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MSScott S Zamvil, Lawrence Steinman
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Multiple Sclerosis: A Virus-Induced Gliopathy?Joseph J Sabatino, Lawrence Steinman
Human Vaccines & Immunotherapeutics|April 1, 2016
Mechanistic insights into influenza vaccine-associated narcolepsyS Sohail Ahmed, Lawrence Steinman
Neuron|June 12, 2003
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosisScott S Zamvil, Lawrence Steinman
Annals of Neurology|June 28, 2006
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisLawrence Steinman, Scott S Zamvil
Annals of Neurology|October 30, 2010
Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosisLawrence Steinman, Scott S Zamvil
Nature Immunology|April 22, 2009
Gaining entry to an uninflamed brainRobert C Axtell, Lawrence Steinman
Cell Research|June 3, 2008
The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in diseasePeggy P Ho, Lawrence Steinman
Cell|January 23, 2026
Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosisLawrence Steinman, Scott S Zamvil
Pageof 34

Showing results (61-70 of 335) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|March 7, 2006
What went wrong in the natalizumab trials?Annette Langer-Gould, Lawrence Steinman
Neurology|October 9, 2002
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MSScott S Zamvil, Lawrence Steinman
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Multiple Sclerosis: A Virus-Induced Gliopathy?Joseph J Sabatino, Lawrence Steinman
Human Vaccines & Immunotherapeutics|April 1, 2016
Mechanistic insights into influenza vaccine-associated narcolepsyS Sohail Ahmed, Lawrence Steinman
Neuron|June 12, 2003
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosisScott S Zamvil, Lawrence Steinman
Annals of Neurology|June 28, 2006
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisLawrence Steinman, Scott S Zamvil
Annals of Neurology|October 30, 2010
Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosisLawrence Steinman, Scott S Zamvil
Nature Immunology|April 22, 2009
Gaining entry to an uninflamed brainRobert C Axtell, Lawrence Steinman
Cell Research|June 3, 2008
The aryl hydrocarbon receptor: a regulator of Th17 and Treg cell development in diseasePeggy P Ho, Lawrence Steinman
Cell|January 23, 2026
Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosisLawrence Steinman, Scott S Zamvil
Pageof 34